Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin after sleeve gastrectomy for early postoperative weight loss
IRCT20190128042520N8Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of metformin in class III obesity, sponsored by Iran University of Medical Sciences. Primary endpoint: Weight loss. Started Dec 2024; status: completed.
02
Drugs
metformin
03
Conditions
class III obesity
Beyond the preview
Go deeper on IRCT20190128042520N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190128042520N8.